Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
Céleste ChevalierMiriam WendnerAnna SulingErsin CavusKai MuellerleileGunnar LundPaulus F KirchhofMonica PattenPublished in: Life (Basel, Switzerland) (2022)
Serum biomarkers such as N-terminal prohormone of the brain natriuretic peptide (NT-proBNP) and cardiac troponins are elevated in patients with hypertrophic cardiomyopathy (HCM). At present, it is not clear if these markers are associated with distinct clinical alterations in HCM, such as left ventricular hypertrophy, outflow tract obstruction, myocardial fibrosis and/or diastolic dysfunction (DD), which are associated with adverse cardiovascular outcome. Here we evaluate the association of NT-proBNP and high sensitivity cardiac troponin T (hs-cTnT) to a variety of cardiac imaging parameters in HCM patients in a multivariable regression analysis. This retrospective cross-sectional study included 366 HCM patients who underwent transthoracic echocardiography (TTE), 218 of whom also obtained cardiovascular magnetic resonance (CMR) to assess focal myocardial fibrosis by LGE. Multivariable regression analyses revealed the strongest association of the DD parameters E/E' mean and E/E' septal with NT-proBNP (b = 0.06, 95%-CI [0.05-0.07], p < 0.001, R 2 = 0.28; b = 0.08, 95%-CI [0.06-0.1], p < 0.001, R 2 = 0.25) and LGE size showed the strongest association with hs-cTnT (b = 0.20, 95%-CI [0.15-0.24], p < 0.001, R 2 = 0.28). This study indicates that NT-proBNP and hs-cTnT are associated with structural and functional alterations in HCM. NT-proBNP is a stronger predictor for DD, while hs-cTnT is associated with the extent of focal myocardial fibrosis. Both biomarkers might be useful in the diagnostic procedure in addition to imaging parameters.
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- cardiac resynchronization therapy
- acute myocardial infarction
- heart failure
- aortic stenosis
- mitral valve
- left atrial
- end stage renal disease
- magnetic resonance
- ejection fraction
- high resolution
- newly diagnosed
- chronic kidney disease
- prognostic factors
- oxidative stress
- peritoneal dialysis
- multiple sclerosis
- magnetic resonance imaging
- blood pressure
- pulmonary hypertension
- white matter
- acute coronary syndrome
- liver fibrosis
- resting state
- brain injury
- cerebral ischemia